2 years ago
NVAX
AnalystsAlec StranahanAlec Stranahan's Stock Forecasts
AnalystsAlec Stranahan
Analyst Ranking
Bottom 1%
#5493 out of 5510 analysts
Average Return
-33.38%
Win Rate
41%15 out of 37
Risk vs Reward
Poor
Good
Alec Stranahan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Krystal Biotech IncKRYS | +123.21% | $151.90 | $339.06 | 2025-07-22 - 2026-07-21 | Strong Buy |
Turning Point Therapeutics IncTPTX | +106.89% | $36.74 | $76.01 | 2022-05-20 - 2022-08-16 | Strong Buy |
Novavax IncNVAX | +86.62% | $53.42 | $7.15 | 2022-05-20 - 2023-05-19 | Sell |
Krystal Biotech IncKRYS | +78.75% | $190.23 | $340.03 | 2025-10-17 - 2026-09-14 | Strong Buy |
Revolution Medicines IncRVMD | +55.46% | $28.38 | $44.12 | 2024-01-05 - 2025-01-03 | Strong Buy |
Alec Stranahan Analyst Color
Get additional color on Alec Stranahan's coverage of popular stocks
2 years ago
NVAX
Alec Stranahan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $8.00 | +330.11% | Initiates Coverage On | a month ago |
Caribou Biosciences IncCRBU | 2 | Strong Buy | $5.00 | +287.60% | Maintains | a month ago |
Candel Therapeutics IncCADL | 3 | Hold | $12.00 | +12.41% | Maintains | a month ago |
Erasca IncERAS | 6 | Hold | $20.00 | +23.76% | Maintains | a month ago |
Perspective Therapeutics IncCATX | 3 | Hold | $5.00 | +71.23% | Maintains | a month ago |
Krystal Biotech IncKRYS | 7 | Strong Buy | $396.00 | +16.46% | Maintains | 2 months ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $47.00 | +94.86% | Reiterates | 2 months ago |
Hutchmed LtdHCM | 1 | Strong Buy | $17.00 | +24.45% | Maintains | 2 months ago |
Tg Therapeutics IncTGTX | 3 | Sell | $20.00 | -62.96% | Maintains | 2 months ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $46.00 | +38.47% | Maintains | 2 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $35.00 | +116.32% | Initiates Coverage On | 3 months ago |
Wave Life Sciences IncWVE | 1 | Strong Buy | $21.00 | +358.52% | Maintains | 6 months ago |
Xencor IncXNCR | 2 | Hold | $12.00 | N/A | Downgrades | a year ago |
Novavax IncNVAX | 5 | Sell | $7.00 | N/A | Downgrades | a year ago |
Y Mabs Therapeutics IncYMAB | 5 | Hold | $12.00 | N/A | Maintains | 2 years ago |
Day One Biopharmaceuticals IncDAWN | 5 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Hookipa Pharma IncHOOK | 1 | Sell | $5.00 | N/A | Downgrades | 4 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Turning Point Therapeutics IncTPTX | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.